PMC:7243778 / 763-927
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T5 | 33-37 | Body_part | denotes | back | http://purl.org/sig/ont/fma/fma25056 |
| T6 | 65-69 | Body_part | denotes | body | http://purl.org/sig/ont/fma/fma256135 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T11 | 0-8 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activate |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T3 | 130-138 | http://purl.obolibrary.org/obo/GO_0007612 | denotes | Learning |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T10 | 39-129 | Sentence | denotes | Exploiting this nature of body protection, neutralizing antibodies have been investigated. |